课题基金 / 基金详情

COMPARISON OF THE VIROLOGIC EFFECACY OF NELFINAVIR AND/OR DMP-266 IN COMBINATION

COMPARISON OF THE VIROLOGIC EFFECACY OF NELFINAVIR AND/OR DMP-266 IN COMBINATION
奈非那韦和/或 DMP-266 组合的病毒学功效比较
批准号:
6118465
负责人:
MARGRIT CARLSON
金额:
$0.19万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MARGRIT CARLSON的其他基金

相似基金

相关文献

中文摘要
翻译
这是一项针对ACTG 302/303受试者的随机化、部分双盲试验,这些受试者最初随机接受d4 T单药治疗或新的联合核苷治疗,并且在入组本转换方案时仍接受其最初分配的治疗。
英文摘要
This is a randomized, partyially double-blind trial for ACTG 302/303 participant who were originally randomized to d4T monotherapy or new combination nucleoside therapy and who remain on their originally assigned treatment at the time of enrollment into this rollover protocol.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PHASE II STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY OF QUADRIVALENT: HIV
FLUCONAZOLE AS CHRONIC SUPPRESSIVE VS EPISODIC THERAPY IN HIV PATIENT
COMPARISON OF THE VIROLOGIC EFFECACY OF NELFINAVIR AND/OR DMP-266 IN COMBINATION
ANTIVIRAL ACTIVITY OF T 20 ADMINISTERED TO HIV 1 POSITIVE ADULTS
海外基金